Literature DB >> 2808793

Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis.

S B Gruber1, R L Barnhill, K S Stenn, G C Roush.   

Abstract

Two hundred forty-eight cases of melanoma accessioned from 1984 through 1985 were independently reviewed by a panel of dermatopathologists for the presence of nevomelanocytic proliferations in histologic contiguity with melanoma. One hundred ninety-seven cases remained in the sample for analysis after cases with insufficient histologic material and those diagnosed without primary melanoma were excluded. We found that 32.5% of melanomas (95% confidence interval, 25.9% to 39.7%) were associated with a benign or dysplastic nevus in histologic contiguity. Melanoma type and anatomic location were significant predictors of contiguous nevomelanocytic proliferations when considered alone. After adjustment, however, only melanoma type significantly predicted the presence of a contiguous histologic evidence of a precursor nevus than was nodular melanoma (odds ratio, 11.1; 95% confidence interval, 1.4 to 86.6) and were almost 22 times more likely to be associated with a nevus than was lentigo maligna melanoma (odds ratio, 21.45; 95% confidence interval, 2.8 to 162.4). This evidence supports the concept of the heterogeneity of melanoma histogenesis.

Entities:  

Mesh:

Year:  1989        PMID: 2808793     DOI: 10.1016/s0190-9622(89)70253-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  An extrafacial amelanotic lentigo maligna of the leg: a case report.

Authors:  Antonella Tammaro; Diego Orsini; Alessandra Narcisi; Giorgia Cortesi; Francesca R Parisella; Veronica Giulianelli; Claudia Abruzzese; Severino Persechino
Journal:  Int Wound J       Date:  2014-08-14       Impact factor: 3.315

2.  mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.

Authors:  William Damsky; Goran Micevic; Katrina Meeth; Viswanathan Muthusamy; David P Curley; Manjula Santhanakrishnan; Ildiko Erdelyi; James T Platt; Laura Huang; Nicholas Theodosakis; M Raza Zaidi; Scott Tighe; Michael A Davies; David Dankort; Martin McMahon; Glenn Merlino; Nabeel Bardeesy; Marcus Bosenberg
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

3.  Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index.

Authors:  D M Berman; S Wincovitch; S Garfield; M J Romeo
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  p15 Expression Differentiates Nevus from Melanoma.

Authors:  Laura A Taylor; Conor O'Day; Tzvete Dentchev; Kyle Hood; Emily Y Chu; Todd W Ridky; John T Seykora
Journal:  Am J Pathol       Date:  2016-11-14       Impact factor: 4.307

5.  CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.

Authors:  Andrew S McNeal; Kevin Liu; Vihang Nakhate; Christopher A Natale; Elizabeth K Duperret; Brian C Capell; Tzvete Dentchev; Shelley L Berger; Meenhard Herlyn; John T Seykora; Todd W Ridky
Journal:  Cancer Discov       Date:  2015-07-16       Impact factor: 39.397

6.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 7.  Moles and melanoma--new method in the madness.

Authors:  R L Barnhill
Journal:  West J Med       Date:  1994-04

Review 8.  [Pigmented lesions of the genital mucosa].

Authors:  U R Hengge; M Meurer
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

9.  Melanocyte transformation associated with substrate adhesion impediment.

Authors:  Sueli M Oba-Shinjo; Mariangela Correa; Tatiana I Ricca; Fernanda Molognoni; Maria A Pinhal; Izabel A Neves; Sueli K Marie; Lúcia O Sampaio; Helena B Nader; Roger Chammas; Miriam G Jasiulionis
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

10.  Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression.

Authors:  J A Reed; N S McNutt; A P Albino
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.